1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Drug Delivery Insight 01 DECEMBER 2014

Drug Delivery Insight 01 DECEMBER 2014

  • December 2014
  • -
  • Espicom Business Intelligence
  • -
  • 16 pages

Industry Trend Analysis - Adherence Concerns To Spur New Technology Introductions
Industry Trend Analysis - Sights Firmly Set On Animal Health As Bayer Seeks Diabetes Exit
Industry Brief - Medical Device Tax Causes B Braun To Shelve US HQ Expansion Plans
Industry Trend Analysis - FDA-Approved Hysingla ER Places Pressure On Zohydro ER
Industry Brief - AirFluSal Forspiro Approved In Ireland/Czech Republic
Industry Brief - Duaklir Genuair Granted EU Marketing Authorisation
Industry Brief - EC Approves Lilly's Trulicity For Type II Diabetes
Industry Brief - flutiform Now Available In Spain And Italy
Industry Brief - Kyorin Markets flutiform 120-Puff Version In Japan
Industry Trend Analysis - Avanir's Inhaled Migraine Therapy Is Delayed But Will Gain FDA Approval
Industry Brief - Zeneo MTX NeedleFree Injection Device Effective In Bioequivalence Study
Industry Brief - Janssen Submits NDA To FDA For Three-Month Paliperidone Palmitate
Industry Brief - Enrolment Completed In Probuphine Phase III Study For Opioid Dependence
Industry Brief - FDA Grants Fast Track Designation To Novavax' RSV F Vaccine
Industry Brief - Concordia Updates On Photofrin Phase III Trial
Industry Brief - Cynapsus Reports Positive Top-Line Phase II Results For Off Episodes In PD
Industry Brief - FDA Grants QIDP Designation To Bayer's Amikacin Inhale/Ciprofloxacin DPI
Industry Brief - IRadimed Files 510(k) Submission For MRI IV System Following FDA Instruction
Industry Brief - Futura Updates On Pain Relief Clinical Programme
Industry Brief - Drug Delivery Conferences - December 2014

Table Of Contents

Drug Delivery Insight 01 DECEMBER 2014

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests,  Opport

2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests, Opport

  • $ 47500
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-company survey from VPGMarketResearch.com contains 1,650 pages and 890 tables. The report provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein ...

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.